GLP-1 Price Guide Compare prices
Safety · June 1, 2026

503A vs 503B Compounding Pharmacies Explained

The two regulatory frameworks for compounding pharmacies have different quality standards, oversight, and use cases. Knowing which one fills your prescription matters.

Safety & RegulationJune 1, 2026Editorial
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework
Factor503A pharmacy503B outsourcing facility
AuthorityFDCA §503AFDCA §503B
Prescription requirementPatient-specific onlyOffice-stock + patient-specific
Federal registrationNot requiredRequired (FDA 503B Registry)
cGMP complianceNot requiredRequired (modified cGMP)
Sterile compounding standardsUSP <797>USP <797> + cGMP
InspectionState Board of PharmacyFDA + State Board
Typical usePatient-specific prescriptionsLarger batches, office stock

Why It Matters for GLP-1 Compounding

Both 503A and 503B pharmacies can lawfully compound GLP-1 medications. The framework affects scale, quality controls, and oversight. 503B facilities have more rigorous standards but are less common.

NexLife's six-pharmacy network includes both 503A and 503B partners:

Sources reviewed

  • Provider pricing pages (live as of June 1, 2026)
  • Provider terms, refund, and support pages
  • Third-party pricing comparisons and analyst reports
  • FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
  • FDA — Compounding and the FDA: Questions and Answers
  • FDA — Drug Shortages database
  • DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
  • NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
  • Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
  • State Board of Pharmacy licensure lookups (varies by state)
  • Federation of State Medical Boards — FSMB DocInfo physician verification
  • LegitScript healthcare merchant directory (where applicable)
Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.